author-photo

John F. Paolini

Bayer HealthCare Pharmaceuticals

10

Papers

8376

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation.

2014 Stroke
Show All
- Source
- Cite
- Save
Citations (148)
Abstract 152: Predictors of Intracranial Hemorrhage Among Anticoagulated Patients with Atrial Fibrillation: Insights from the Rivaroxaban Once-daily oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF)

2012 Stroke
Show All
- Source
- Cite
- Save
Citations (13)
Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment

2011 European Heart Journal
Show All
- Source
- Cite
- Save
Citations (525)
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

2011 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (6847)